NALBUPHIN OrPha sol inj 20 mg/2ml 10 amp 2 ml
7680569890026
CH-56989
N02AF02
01.01.3.
1 / 3
google
Details
- Product number
- 5698901
- CPT
- -
- Packaging group
- 10 x 2
- Unit
- ml
- Composition
- nalbuphini hydrochloridum 20 mg, natrii chloridum, acidum citricum, natrii citras dihydricus, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 1.64 mg.
Articles (1)
Nalbuphin OrPha, Injektionslösung
Injektionslösung
10 x 2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.64 MG | Substance | HBESI |
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 56989
- Drug name
- Nalbuphin OrPha, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- N02AF02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/10/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NALBUPHIN OrPha sol inj 20 mg/2ml 10 amp 2 ml
- Description (DE)
- NALBUPHIN OrPha Inj Lös 20 mg/2ml 10 Amp 2 ml
- Market launch
- 15/10/2004
- Narcotic (BTM)
- No